Rating History for Avalyn Pharma (AVLN) by Evercore ISI
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/26/2026 | Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
N/A (N/A) |
28.84 (32.97) |
14.32% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/26/2026 | Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
N/A (N/A) |
28.84 (32.97) |
14.32% | Details |